Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • maricu
    Junior Member
    • Apr 2010
    • 8

    #1

    BWA mapping fastq files with Illumina quality

    Hello,

    I am still new in these matters, I was told to map illumina reads to the human genome. I was given the fastq files and proceeded to use BWA, everything ran smoothly 'til today when I realised the reads I had mapped had the Illimina base qualities instead of Sanger's . This raised several questions: Why can BWA map fastq files with the Illumina instead of Sanger? What are the consequences of this?? Unmapped reads?? miscalled variants?? I am pretty concerned since the mapping took around two weeks and I am not sure if I need to start from scratch again and remap the fastqs in sanger format. Please, any help will be highly appreciated!!

    Tanks,

    Maria
  • nilshomer
    Nils Homer
    • Nov 2008
    • 1283

    #2
    BWA does not consider quality scores so you need to convert the quality scores in the SAM/BAM file to sanger before variant calling.

    Comment

    • m_elena_bioinfo
      Member
      • Oct 2009
      • 99

      #3
      See this post:
      Discussion of next-gen sequencing related bioinformatics: resources, algorithms, open source efforts, etc


      I use the patch (http://sites.google.com/site/davidec...edirects=0&d=1) and the option -I in the alignment to convert quality.
      It's run perfectly (thanks to Dawe)

      ME

      Comment

      • bioinfosm
        Senior Member
        • Jan 2008
        • 483

        #4
        Originally posted by nilshomer View Post
        BWA does not consider quality scores so you need to convert the quality scores in the SAM/BAM file to sanger before variant calling.
        thats a shift from MAQ which does use base Q values to do alignments. Wouldn't BWA achieve greater efficiency in using base quality values of mis-matches to weigh them and penalize accordingly!
        --
        bioinfosm

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
          by SEQadmin2



          Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

          Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
          ...
          10-14-2026, 09:55 AM
        • SEQadmin2
          New Genomics Technologies Take Aim at Long-Standing Limits
          by SEQadmin2


          Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

          We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
          ...
          09-28-2026, 10:25 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, 10-15-2026, 10:52 AM
        0 responses
        16 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-14-2026, 05:39 AM
        0 responses
        21 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-13-2026, 09:56 AM
        0 responses
        22 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-09-2026, 11:14 AM
        0 responses
        27 views
        0 reactions
        Last Post SEQadmin2  
        Working...